Olanzapine Aurobindo Pharma 5 mg tablets Malta - English - Medicines Authority

olanzapine aurobindo pharma 5 mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - tablet - olanzapine 5 mg - psycholeptics

Olanzapine Aurobindo Pharma 10 mg tablets Malta - English - Medicines Authority

olanzapine aurobindo pharma 10 mg tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - tablet - olanzapine 10 mg - psycholeptics

Auro-Simvastatin 10 New Zealand - English - Medsafe (Medicines Safety Authority)

auro-simvastatin 10

aurobindo pharma nz limited - simvastatin 10mg;   - film coated tablet - 10 mg - active: simvastatin 10mg   excipient: ascorbic acid butylated hydroxyanisole citric acid monohydrate starch, pregelatinised (starch 1500) lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 20a54239 - paediatric patients with heterozygous familial hypercholesterolaemia: simvastatin is indicated as an adjunct to diet to reduce total-c, ldl-c, tg, and apo b levels in adolescent boys and girls who are at least one year post-menarche, 10-17 years of age, with heterozygous familial hypercholesterolaemia (hefh).

Auro-Simvastatin 20 New Zealand - English - Medsafe (Medicines Safety Authority)

auro-simvastatin 20

aurobindo pharma nz limited - simvastatin 20mg;   - film coated tablet - 20 mg - active: simvastatin 20mg   excipient: ascorbic acid butylated hydroxyanisole citric acid monohydrate starch, pregelatinised (starch 1500) lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 20a54239 - paediatric patients with heterozygous familial hypercholesterolaemia: simvastatin is indicated as an adjunct to diet to reduce total-c, ldl-c, tg, and apo b levels in adolescent boys and girls who are at least one year post-menarche, 10-17 years of age, with heterozygous familial hypercholesterolaemia (hefh).

Auro-Simvastatin 40 New Zealand - English - Medsafe (Medicines Safety Authority)

auro-simvastatin 40

aurobindo pharma nz limited - simvastatin 40mg;   - film coated tablet - 40 mg - active: simvastatin 40mg   excipient: ascorbic acid butylated hydroxyanisole citric acid monohydrate starch, pregelatinised (starch 1500) lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 20a54211 - paediatric patients with heterozygous familial hypercholesterolaemia: simvastatin is indicated as an adjunct to diet to reduce total-c, ldl-c, tg, and apo b levels in adolescent boys and girls who are at least one year post-menarche, 10-17 years of age, with heterozygous familial hypercholesterolaemia (hefh).

Auro-Simvastatin 5 New Zealand - English - Medsafe (Medicines Safety Authority)

auro-simvastatin 5

aurobindo pharma nz limited - simvastatin 5mg;   - film coated tablet - 5 mg - active: simvastatin 5mg   excipient: ascorbic acid butylated hydroxyanisole citric acid monohydrate lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 20a52229 starch - paediatric patients with heterozygous familial hypercholesterolaemia: simvastatin is indicated as an adjunct to diet to reduce total-c, ldl-c, tg, and apo b levels in adolescent boys and girls who are at least one year post-menarche, 10-17 years of age, with heterozygous familial hypercholesterolaemia (hefh).

Auro-Simvastatin 80 New Zealand - English - Medsafe (Medicines Safety Authority)

auro-simvastatin 80

aurobindo pharma nz limited - simvastatin 80mg;   - film coated tablet - 80 mg - active: simvastatin 80mg   excipient: ascorbic acid butylated hydroxyanisole citric acid monohydrate starch, pregelatinised (starch 1500) lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 20a54211 - paediatric patients with heterozygous familial hypercholesterolaemia: simvastatin is indicated as an adjunct to diet to reduce total-c, ldl-c, tg, and apo b levels in adolescent boys and girls who are at least one year post-menarche, 10-17 years of age, with heterozygous familial hypercholesterolaemia (hefh).

Compound Sodium Lactate Solution For Infussion SODIUM LACTATE B.P 0.320% W/V,SODIUM CHLORIDE B.P. 0.600 % W/V,POTASSIUM CHLORIDE B.P 0.040 % W/V,CALCIUM CHLORIDE DIHYDRATE B.P. 0.027 % W/V Tanzania - English - Tanzania Medicinces & Medical Devices Authority

compound sodium lactate solution for infussion sodium lactate b.p 0.320% w/v,sodium chloride b.p. 0.600 % w/v,potassium chloride b.p 0.040 % w/v,calcium chloride dihydrate b.p. 0.027 % w/v

abacus parenteral drugs limited, uganda - calcium chloride bp , sodium chloride bp , potassium chloride bp , sodium lactate usp - solution for infussion - sodium lactate b.p 0.320% w/v,sodium chloride b.p. 0.600 % w/v,potassium chloride b.p 0.040 % w/v,calcium chloride dihydrate b.p. 0.027 % w/v